Is Omicron the “Scrooge” or Could it be the “Ideal” Variant to Put an End to the Pandemic?

Although Omicron is now 73% of all new cases in the US[1],  I don’t feel we need to press the panic button. I have some hypotheses on the emergence of the Omicron variant that could put the brakes on the doom and gloom scenario we are all being fed. According to a study published on …

Ivermectin as a Prophylactic and Treatment for COVID-19

Having effective therapeutics is going to be increasingly important when it comes to confronting Covid-19 and the evolution of new variants. First detected in Japan, the R1 variant is the newest strain of COVID-19 that contains “multiple spike protein mutations”, that could enable it to bypass the antibody protection present in those who are fully vaccinated. …

Weighing the Risk-to-Benefit Ratio of COVID-19 Vaccines

Given the ongoing discord within the scientific community regarding the short-term and long-term efficacy and safety of the different types of anti-SARS-CoV-2 vaccines, their experimental nature, and the availability of other therapeutic approaches,[1] such information should be universal and should be provided to every potential vaccine recipient. The safety and tolerance of COVID-19 vaccines must be …

Synthesizing the Latest on Covid-19 Science on Vaccines, Variants, Natural Immunity and Essential Nutrients for Immune Enhancement

I can’t emphasize enough the importance of normalizing your vitamin D, zinc, and magnesium levels, as well as eating an abundance of whole foods such as fruits, vegetables, and whole grains, pre and probiotic foods, and legumes, such as lentils. There is still so much we need to know and will come to learn about COVID-19 over time. Let’s keep an open mind and continue to seek the truth and be respectful of others whose thoughts, feelings, and opinions may differ from those of our own.

COVID-19 Vaccines, Variants, Immune Health and Traditional Medicine Use Across the Globe

In the aggressive response to the global health emergency, many are having a hard time trying to find reliable data to effectively address a host of concerns about the virus itself, as well as the short and long-term risks associated with the new vaccines (currently Moderna and Pfizer), especially due to their origins (mRNA), potential …